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Aim of the study
The incidence of the gastric cancer is 23% of all the
tumours in Europe, and increases with progressing by age
with a prevalence of 140 by 100,000/year for the subjects
with more than 75 years. To the light of this consideration
we analysed retrospectively the results obtained with the
surgical therapy of the gastric cancer in the elderly patient.
Materials and methods
From 1989 to 2007, 291 consecutive patients underwent
surgical resection with curative (R0) intent. We have col-
lected and analysed data concerning the characteristics of
the patients, type of surgical treatment and the tumour
itself. Data processing was performed using SPSS 13.0 for
Windows Evaluation Version (SPSS Inc., Chicago, IL,
USA).
Results
Mean age was 65.7 years (± 11.22). Patients were divided
into 2 groups: ≤70 years ("young") and >71 years
("elders"). The first group included 177 patients (60.8%),
and the second 114 (39.2%). ASA score has been
expressed in all the cases: 81.9% of the young patients had
ASA 1–2, while 96.5% of the elderly patients had an ASA
between 2 and 3 (p < 0.0001). Other significant difference
has been the higher tumoral infiltration level (T) in the
group of young patients (p = 0.035). As regards the lym-
phonode involvement we have considered the Lymphon-
ode ratio (LR). The observed values have been assembled
in three categories: 0%, 1–30% and >31%. In young peo-
ple we have respectively observed for the three categories
a rate of 40.1%, 33.3% and 26.6%, while in the elders
53.3%, 28.1% and 18.4% (N.S). However, taking into
consideration the stage of the tumor, a tendency emerged
in young people to show a more advanced stage with
respect to the elderly patients (p = 0.026). The evaluation
of the histological type according to Lauren has high-
lighted the presence of the diffuse pattern in 54.2% of
young people with respect to the 36.0% of the elders (p =
0.002). Post-operative morbidity, divided into those of
infectious type (abscesses, peritonitis, sepsis), cardio-res-
piratory and techniques (anastomotic leak) have respec-
tively, in young and elders group, of 5.1% and 7.9%
(infectious); (p = ns), cardio-respiratory of 6.2% and
19.3% (p = 0.001), anastomotic leak of 2.3% and 5.3% (p
= ns). Actuarial survival at 1 and 5 years has been respec-
tively 84.7% and 44% in the young group, and 72.8% and
31.6% in the elderly (p = 0.002), (Figure 1). But these dif-
ferences disappear comparing survival and the ASA score
between groups (Figures 2, 3).
The rate of tumor relapse has been of 41.2% in young peo-
ple and 28.9% (p = 0.033) in the elders. At the multivari-
ate analysis stage of the disease and the ASA score resulted
negative prognostic factors for young patients, while LR,
ASA score and anastomotic leak in the elders group.
Conclusion
Age is not a factor limiting surgical therapy for patients
affected by gastric cancer. Patients over 70 benefit from
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free survival with an outcome comparable to the young
patients. Particular attention must be placed to rule out
and correct invalidating systemic pathologies.
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